Celgene and Novartis Sue Teva Pharmaceuticals

  • December 8, 2011

Celgene and Novartis filed suit against Teva Pharmaceuticals over six patents related to phenidate drug formulations with diminished abuse potential.  12/2, District of New Jersey, 2:2011cv07064.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×